As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect with many T1D thought leaders that will participate in t ...
Nobel winners' mapping of ribosomes helps in development of new antibiotics (CNN)-- Two Americans and an Israeli were awarded the Nobel Prize in chemistry on Wednesday for painstakingly mapping out ...
Roche Holding AG's acquisition of 89bio, Inc. to expand cardiometabolic offerings and drive growth beyond GLP-1. Click for ...
Roche acquires 89bio for up to $3.5B, betting on pegozafermin for MASH. Click here to read the latest analysis on ETNB and ...
Zacks Investment Research on MSN
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Entera Bio Ltd. ENTX recently reported encouraging pharmacokinetic data, underscoring the potential of its first-in-class oral GLP-2 analog therapy for patients with short bowel syndrome (SBS). The ...
The NT has assembled a young and exciting group of riders keen to take on the challenge of the MXGP and show their stuff on ...
These hilarious but underrated sitcoms deserve a spot in your rewatch rotation, from Happy Endings to Superstore.
As a data science student, Jennifer treats her hobbies like an experiment, where failure is an important part of the learning process. She also loves running, playing ultimate frisbee and learning to ...
Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion - ...
Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion - - Transaction reflects the potential of Tourmaline's pacibekitug, a long-acting ...
– 89bio to join the Roche Group as part of Roche’s Pharmaceuticals Division – ...
Microsoft is betting big on this class of laptops with built-in AI processing. Here's what sets these systems apart right now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results